Molnupiravir is a type of antiviral medication specifically developed to combat COVID-19. It works by interfering with the replication process of the virus, effectively stopping it from spreading further within the body. This medication has shown promise in reducing the severity of illness and shortening the duration of symptoms during clinical trials.
What makes molnupiravir particularly noteworthy is its potential for at-home use, which could potentially lessen the strain on healthcare systems. However, as with any medication, it is important to consult with healthcare professionals before use to ensure its appropriateness and to be aware of any potential side effects.
| CAS | 2349386-89-4 |
| Country Of Origin | China |
| Manufacturer | LongilatBio |
| Molecular Formula | C13H19N3O7 |
| Indication | Treatment Of COVID-19 |
| Generic Name | EIDD-2801 |
| Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
| Purity | 99% |
| COA | Available |
1~25kgs packaging: Aluminium bag inside, Carton box outside.
25kgs packaging: Plastic bag inside, Fiber drum outside
